Table 6.
Baseline-9 months | 9–18 months | Odds ratio | |||
---|---|---|---|---|---|
n | % | n | % | ||
AQ study† (n=44) | 0 | 0.0 | 1 | 2.3 | − |
Lyo study (n=50) | 0 | 0.0 | 0 | 0.0 | − |
Spanish study (n=69) | 2 | 2.9 | 0 | 0.0 | 0.00 |
*Presence of an anti-GH antibody is defined by at least two consecutive positive test results.
†Group B of AQ study.